{
  "DOI": "10.1186/s40246-021-00349-w",
  "ISSN": [
    "1479-7364"
  ],
  "URL": "http://dx.doi.org/10.1186/s40246-021-00349-w",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eBackground\u003c/jats:title\u003e\n                \u003cjats:p\u003ePrevious studies indicated that lncRNA taurine upregulated gene 1 (TUG1) played essential roles in human cancers. This study aimed to investigate its function in infantile hemangioma (IH).\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eMethods\u003c/jats:title\u003e\n                \u003cjats:p\u003eA total of 30 pairs of clinical infantile specimens were used in this study. The expression of TUG1 in IH tissues was assessed by quantitative reverse transcriptase PCR (qRT-PCR). Two short hairpin RNA targeting TUG1 (sh-TUG1-1 and sh-TUG1-2) were transfected into hemangioma-derived endothelial cells, HemECs, to block its expression. The effects of TUG1 on HemECs were evaluated by Cell Counting Kit-8 (CCK-8), colony formation assay, wound healing assay, and Transwell assay. The underlying molecular mechanism of TUG1 was investigated by Starbase prediction and luciferase reporter assay and further determined by loss- and gain-of-function approaches. In addition, the role of TUG1 on tumorigenesis of HemECs was confirmed in an in vivo mouse model.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eResults\u003c/jats:title\u003e\n                \u003cjats:p\u003eTUG1 was significantly upregulated in infant hemangioma tissues compared with normal adjacent subcutaneous tissues. The loss- and gain-of-function approaches indicated that TUG1 overexpression promoted proliferation, migration, and invasion of HemECs in vitro, and TUG1 knockdown inhibited the tumorigenesis of HemECs in vivo. Specifically, TUG1 could compete with IGFBP5 for miR137 binding. Rescue experiments further confirmed the role of the TUG1/miR137/IGFBP5 axis in HemECs.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e\u003cjats:sec\u003e\n                \u003cjats:title\u003eConclusion\u003c/jats:title\u003e\n                \u003cjats:p\u003eTUG1 was closely associated with the progression of IH by regulating the miR-137/IGFBP5 axis, which might be a potential target for IH treatment.\u003c/jats:p\u003e\n              \u003c/jats:sec\u003e",
  "alternative-id": [
    "349"
  ],
  "article-number": "50",
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "12 February 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "22 July 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "6 August 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Ethics approval and consent to participate",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "This study was approved by the Human Ethics Committee of Beijing University of Chinese Medicine Shenzhen Hospital (Longgang) and conducted in accordance with the Guidelines of the Declaration of Helsinki. All participants have written to obtain the informed consent of their parents/legal guardians."
    },
    {
      "group": {
        "label": "Consent for publication",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 3,
      "value": "Not applicable."
    },
    {
      "group": {
        "label": "Competing interests",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 4,
      "value": "The authors declare that they have no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Zhou",
      "given": "Lili",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Jia",
      "given": "Xiao",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Yang",
      "given": "Xiangzheng",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genomics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        8,
        6
      ]
    ],
    "date-time": "2021-08-06T07:03:23Z",
    "timestamp": 1628233403000
  },
  "deposited": {
    "date-parts": [
      [
        2021,
        8,
        6
      ]
    ],
    "date-time": "2021-08-06T07:11:36Z",
    "timestamp": 1628233896000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        17
      ]
    ],
    "date-time": "2024-04-17T01:32:32Z",
    "timestamp": 1713317552176
  },
  "is-referenced-by-count": 5,
  "issn-type": [
    {
      "type": "electronic",
      "value": "1479-7364"
    }
  ],
  "issue": "1",
  "issued": {
    "date-parts": [
      [
        2021,
        8,
        6
      ]
    ]
  },
  "journal-issue": {
    "issue": "1",
    "published-print": {
      "date-parts": [
        [
          2021,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            8,
            6
          ]
        ],
        "date-time": "2021-08-06T00:00:00Z",
        "timestamp": 1628208000000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            8,
            6
          ]
        ],
        "date-time": "2021-08-06T00:00:00Z",
        "timestamp": 1628208000000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-021-00349-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1186/s40246-021-00349-w/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1186/s40246-021-00349-w.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "prefix": "10.1186",
  "published": {
    "date-parts": [
      [
        2021,
        8,
        6
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        8,
        6
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2021,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1002/lsm.22455",
      "author": "S Chinnadurai",
      "doi-asserted-by": "publisher",
      "first-page": "221",
      "issue": "3",
      "journal-title": "Lasers Surg Med",
      "key": "349_CR1",
      "unstructured": "Chinnadurai S, Sathe NA, Surawicz T. Laser treatment of infantile hemangioma: A systematic review. Lasers Surg Med. 2016;48(3):221–33. https://doi.org/10.1002/lsm.22455.",
      "volume": "48",
      "year": "2016"
    },
    {
      "DOI": "10.21037/atm.2019.10.47",
      "author": "ZY Chen",
      "doi-asserted-by": "publisher",
      "first-page": "692",
      "issue": "22",
      "journal-title": "Annals of translational medicine",
      "key": "349_CR2",
      "unstructured": "Chen ZY, Wang QN, Zhu YH, Zhou LY, Xu T, He ZY, et al. Progress in the treatment of infantile hemangioma. Annals of translational medicine. 2019;7(22):692. https://doi.org/10.21037/atm.2019.10.47.",
      "volume": "7",
      "year": "2019"
    },
    {
      "DOI": "10.1016/S0140-6736(16)00645-0",
      "author": "C Léauté-Labrèze",
      "doi-asserted-by": "publisher",
      "first-page": "85",
      "issue": "10089",
      "journal-title": "Lancet (London, England)",
      "key": "349_CR3",
      "unstructured": "Léauté-Labrèze C, Harper JI, Hoeger PH. Infantile haemangioma. Lancet (London, England). 2017;390(10089):85–94.",
      "volume": "390",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41598-017-10674-7",
      "author": "L Yang",
      "doi-asserted-by": "publisher",
      "first-page": "11846",
      "issue": "1",
      "journal-title": "Sci Rep",
      "key": "349_CR4",
      "unstructured": "Yang L, Dai J, Li F, Cheng H, Yan D, Ruan Q. The expression and function of miR-424 in infantile skin hemangioma and its mechanism. Sci Rep. 2017;7(1):11846. https://doi.org/10.1038/s41598-017-10674-7.",
      "volume": "7",
      "year": "2017"
    },
    {
      "DOI": "10.2353/ajpath.2009.080517",
      "author": "ML Calicchio",
      "doi-asserted-by": "publisher",
      "first-page": "1638",
      "issue": "5",
      "journal-title": "Am J Pathol",
      "key": "349_CR5",
      "unstructured": "Calicchio ML, Collins T, Kozakewich HP. Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling. Am J Pathol. 2009;174(5):1638–49. https://doi.org/10.2353/ajpath.2009.080517.",
      "volume": "174",
      "year": "2009"
    },
    {
      "DOI": "10.1007/978-981-10-5203-3_10",
      "author": "S Jathar",
      "doi-asserted-by": "publisher",
      "first-page": "283",
      "journal-title": "Adv Exp Med Biol",
      "key": "349_CR6",
      "unstructured": "Jathar S, Kumar V, Srivastava J, Tripathi V. Technological Developments in lncRNA Biology. Adv Exp Med Biol. 2017;1008:283–323. https://doi.org/10.1007/978-981-10-5203-3_10.",
      "volume": "1008",
      "year": "2017"
    },
    {
      "DOI": "10.1016/j.bbagrm.2014.08.012",
      "author": "G Yang",
      "doi-asserted-by": "publisher",
      "first-page": "1097",
      "issue": "11",
      "journal-title": "Biochim Biophys Acta",
      "key": "349_CR7",
      "unstructured": "Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097–109. https://doi.org/10.1016/j.bbagrm.2014.08.012.",
      "volume": "1839",
      "year": "2014"
    },
    {
      "DOI": "10.2174/1381612826666191227154009",
      "author": "C Guo",
      "doi-asserted-by": "publisher",
      "first-page": "688",
      "issue": "6",
      "journal-title": "Curr Pharm Des",
      "key": "349_CR8",
      "unstructured": "Guo C, Qi Y, Qu J, Gai L, Shi Y, Yuan C. Pathophysiological functions of the lncRNA TUG1. Curr Pharm Des. 2020;26(6):688–700. https://doi.org/10.2174/1381612826666191227154009.",
      "volume": "26",
      "year": "2020"
    },
    {
      "DOI": "10.1097/MD.0000000000012131",
      "author": "T Li",
      "doi-asserted-by": "publisher",
      "issue": "36",
      "journal-title": "Medicine.",
      "key": "349_CR9",
      "unstructured": "Li T, Chen Y, Zhang J, Liu S. LncRNA TUG1 promotes cells proliferation and inhibits cells apoptosis through regulating AURKA in epithelial ovarian cancer cells. Medicine. 2018;97(36):e12131. https://doi.org/10.1097/MD.0000000000012131.",
      "volume": "97",
      "year": "2018"
    },
    {
      "DOI": "10.1093/abbs/gmx047",
      "author": "H Lei",
      "doi-asserted-by": "publisher",
      "first-page": "588",
      "issue": "7",
      "journal-title": "Acta Biochim Biophys Sin",
      "key": "349_CR10",
      "unstructured": "Lei H, Gao Y, Xu X. LncRNA TUG1 influences papillary thyroid cancer cell proliferation, migration and EMT formation through targeting miR-145. Acta Biochim Biophys Sin. 2017;49(7):588–97. https://doi.org/10.1093/abbs/gmx047.",
      "volume": "49",
      "year": "2017"
    },
    {
      "DOI": "10.3892/etm.2019.7880",
      "author": "K Sheng",
      "doi-asserted-by": "publisher",
      "first-page": "3002",
      "issue": "4",
      "journal-title": "Experimental and therapeutic medicine",
      "key": "349_CR11",
      "unstructured": "Sheng K, Li Y. LncRNA TUG1 promotes the development of osteosarcoma through RUNX2. Experimental and therapeutic medicine. 2019;18(4):3002–8. https://doi.org/10.3892/etm.2019.7880.",
      "volume": "18",
      "year": "2019"
    },
    {
      "DOI": "10.1007/s12282-016-0736-x",
      "author": "T Li",
      "doi-asserted-by": "publisher",
      "first-page": "535",
      "issue": "4",
      "journal-title": "Breast cancer (Tokyo, Japan)",
      "key": "349_CR12",
      "unstructured": "Li T, Liu Y, Xiao H, Xu G. Long non-coding RNA TUG1 promotes cell proliferation and metastasis in human breast cancer. Breast cancer (Tokyo, Japan). 2017;24(4):535–43.",
      "volume": "24",
      "year": "2017"
    },
    {
      "DOI": "10.1186/s12967-016-0786-z",
      "author": "J Sun",
      "doi-asserted-by": "publisher",
      "first-page": "42",
      "issue": "1",
      "journal-title": "J Transl Med",
      "key": "349_CR13",
      "unstructured": "Sun J, Ding C, Yang Z, Liu T, Zhang X, Zhao C, et al. The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition. J Transl Med. 2016;14(1):42. https://doi.org/10.1186/s12967-016-0786-z.",
      "volume": "14",
      "year": "2016"
    },
    {
      "DOI": "10.1038/cddis.2015.356",
      "author": "E Zhang",
      "doi-asserted-by": "publisher",
      "issue": "2",
      "journal-title": "Cell Death Dis",
      "key": "349_CR14",
      "unstructured": "Zhang E, He X, Yin D, Han L, Qiu M, Xu T, et al. Increased expression of long noncoding RNA TUG1 predicts a poor prognosis of gastric cancer and regulates cell proliferation by epigenetically silencing of p57. Cell Death Dis. 2016;7(2):e2109. https://doi.org/10.1038/cddis.2015.356.",
      "volume": "7",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.jaci.2017.08.034",
      "author": "TX Lu",
      "doi-asserted-by": "publisher",
      "first-page": "1202",
      "issue": "4",
      "journal-title": "J Allergy Clin Immunol",
      "key": "349_CR15",
      "unstructured": "Lu TX, Rothenberg ME. MicroRNA. J Allergy Clin Immunol. 2018;141(4):1202–7. https://doi.org/10.1016/j.jaci.2017.08.034.",
      "volume": "141",
      "year": "2018"
    },
    {
      "DOI": "10.3892/ijmm.2017.2863",
      "author": "D Li",
      "doi-asserted-by": "publisher",
      "first-page": "757",
      "issue": "3",
      "journal-title": "Int J Mol Med",
      "key": "349_CR16",
      "unstructured": "Li D, Li P, Guo Z, Wang H, Pan W. Downregulation of miR-382 by propranolol inhibits the progression of infantile hemangioma via the PTEN-mediated AKT/mTOR pathway. Int J Mol Med. 2017;39(3):757–63. https://doi.org/10.3892/ijmm.2017.2863.",
      "volume": "39",
      "year": "2017"
    },
    {
      "DOI": "10.1002/jcb.28124",
      "doi-asserted-by": "crossref",
      "key": "349_CR17",
      "unstructured": "Qi J, Wang WW, Chen W, Lu WY, Shang AQ. Mechanism of miR-137 regulating migration and invasion of melanoma cells by targeting PIK3R3 gene. J Cell Biochem. 2018."
    },
    {
      "DOI": "10.1089/cbr.2019.3297",
      "doi-asserted-by": "publisher",
      "key": "349_CR18",
      "unstructured": "Li W, Ge J, Xie J, Yang J, Chen J, He T. LncRNA TUG1 Promotes hepatocellular carcinoma migration and invasion via targeting miR-137/AKT2 axis. Cancer Biother Radiopharm. 2020. https://doi.org/10.1089/cbr.2019.3297."
    },
    {
      "DOI": "10.1353/pbm.2010.0001",
      "author": "S Blumenthal",
      "doi-asserted-by": "publisher",
      "first-page": "491",
      "issue": "4",
      "journal-title": "Perspect Biol Med",
      "key": "349_CR19",
      "unstructured": "Blumenthal S. From insulin and insulin-like activity to the insulin superfamily of growth-promoting peptides: a 20th-century odyssey. Perspect Biol Med. 2010;53(4):491–508. https://doi.org/10.1353/pbm.2010.0001.",
      "volume": "53",
      "year": "2010"
    },
    {
      "DOI": "10.1093/carcin/bgn206",
      "author": "SB Rho",
      "doi-asserted-by": "publisher",
      "first-page": "2106",
      "issue": "11",
      "journal-title": "Carcinogenesis.",
      "key": "349_CR20",
      "unstructured": "Rho SB, Dong SM, Kang S, Seo SS, Yoo CW, Lee DO, et al. Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis. Carcinogenesis. 2008;29(11):2106–11. https://doi.org/10.1093/carcin/bgn206.",
      "volume": "29",
      "year": "2008"
    },
    {
      "DOI": "10.5732/cjc.011.10405",
      "author": "G Güllü",
      "doi-asserted-by": "publisher",
      "first-page": "266",
      "issue": "6",
      "journal-title": "Chinese journal of cancer",
      "key": "349_CR21",
      "unstructured": "Güllü G, Karabulut S, Akkiprik M. Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers. Chinese journal of cancer. 2012;31(6):266–80. https://doi.org/10.5732/cjc.011.10405.",
      "volume": "31",
      "year": "2012"
    },
    {
      "DOI": "10.1210/en.2004-1408",
      "author": "AJ Butt",
      "doi-asserted-by": "publisher",
      "first-page": "3113",
      "issue": "7",
      "journal-title": "Endocrinology.",
      "key": "349_CR22",
      "unstructured": "Butt AJ, Dickson KA, Jambazov S, Baxter RC. Enhancement of tumor necrosis factor-alpha-induced growth inhibition by insulin-like growth factor-binding protein-5 (IGFBP-5), but not IGFBP-3 in human breast cancer cells. Endocrinology. 2005;146(7):3113–22. https://doi.org/10.1210/en.2004-1408.",
      "volume": "146",
      "year": "2005"
    },
    {
      "DOI": "10.1002/1097-4644(20010201)80:2\u003c248::aid-jcb140\u003e3.0.co;2-4",
      "author": "CM Perks",
      "doi-asserted-by": "publisher",
      "first-page": "248",
      "issue": "2",
      "journal-title": "J Cell Biochem",
      "key": "349_CR23",
      "unstructured": "Perks CM, McCaig C, Holly JM. Differential insulin-like growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-5 on apoptosis in human breast cancer cells. Involvement of the mitochondria. J Cell Biochem. 2000;80(2):248–58. https://doi.org/10.1002/1097-4644(20010201)80:2\u003c248::aid-jcb140\u003e3.0.co;2-4.",
      "volume": "80",
      "year": "2000"
    },
    {
      "DOI": "10.1002/cncr.20095",
      "author": "X Hao",
      "doi-asserted-by": "publisher",
      "first-page": "1110",
      "issue": "6",
      "journal-title": "Cancer.",
      "key": "349_CR24",
      "unstructured": "Hao X, Sun B, Hu L, Lähdesmäki H, Dunmire V, Feng Y, et al. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer. 2004;100(6):1110–22. https://doi.org/10.1002/cncr.20095.",
      "volume": "100",
      "year": "2004"
    },
    {
      "author": "T Nishidate",
      "first-page": "797",
      "issue": "4",
      "journal-title": "Int J Oncol",
      "key": "349_CR25",
      "unstructured": "Nishidate T, Katagiri T, Lin ML, Mano Y, Miki Y, Kasumi F, et al. Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis. Int J Oncol. 2004;25(4):797–819.",
      "volume": "25",
      "year": "2004"
    },
    {
      "DOI": "10.1038/s41388-019-0743-4",
      "doi-asserted-by": "crossref",
      "key": "349_CR26",
      "unstructured": "Zhang L, Li W, Cao L, Xu J, Qian Y, Chen H, et al. PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53. 2019;38(23):4590–604."
    },
    {
      "DOI": "10.3892/or.2018.6840",
      "author": "T Zhang",
      "doi-asserted-by": "publisher",
      "first-page": "279",
      "issue": "1",
      "journal-title": "Oncol Rep",
      "key": "349_CR27",
      "unstructured": "Zhang T, Guo J, Gu J, Wang Z, Wang G, Li H, et al. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments. Oncol Rep. 2019;41(1):279–91. https://doi.org/10.3892/or.2018.6840.",
      "volume": "41",
      "year": "2019"
    },
    {
      "DOI": "10.2147/CMAR.S257701",
      "doi-asserted-by": "crossref",
      "key": "349_CR28",
      "unstructured": "Chen X, Yu Q, Pan H. Overexpression of IGFBP5 enhances radiosensitivity through PI3K-AKT pathway in prostate cancer. 2020;12:5409–18."
    },
    {
      "DOI": "10.1186/s13008-020-00061-6",
      "author": "C Dong",
      "doi-asserted-by": "publisher",
      "first-page": "4",
      "issue": "1",
      "journal-title": "Cell Div",
      "key": "349_CR29",
      "unstructured": "Dong C, Zhang J, Fang S, Liu F. IGFBP5 increases cell invasion and inhibits cell proliferation by EMT and Akt signaling pathway in Glioblastoma multiforme cells. Cell Div. 2020;15(1):4. https://doi.org/10.1186/s13008-020-00061-6.",
      "volume": "15",
      "year": "2020"
    },
    {
      "DOI": "10.18632/oncotarget.4114",
      "author": "J Wang",
      "doi-asserted-by": "publisher",
      "first-page": "20636",
      "issue": "24",
      "journal-title": "Oncotarget.",
      "key": "349_CR30",
      "unstructured": "Wang J, Ding N, Li Y, Cheng H, Wang D, Yang Q, et al. Insulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells. Oncotarget. 2015;6(24):20636–49. https://doi.org/10.18632/oncotarget.4114.",
      "volume": "6",
      "year": "2015"
    },
    {
      "DOI": "10.1371/journal.pone.0186245",
      "author": "J Pan",
      "doi-asserted-by": "publisher",
      "issue": "10",
      "journal-title": "PLoS One",
      "key": "349_CR31",
      "unstructured": "Pan J, Li K, Huang W, Zhang X. MiR-137 inhibited cell proliferation and migration of vascular smooth muscle cells via targeting IGFBP-5 and modulating the mTOR/STAT3 signaling. PLoS One. 2017;12(10):e0186245. https://doi.org/10.1371/journal.pone.0186245.",
      "volume": "12",
      "year": "2017"
    },
    {
      "DOI": "10.1182/blood-2006-03-006478",
      "author": "ZA Khan",
      "doi-asserted-by": "publisher",
      "first-page": "915",
      "issue": "3",
      "journal-title": "Blood.",
      "key": "349_CR32",
      "unstructured": "Khan ZA, Melero-Martin JM, Wu X, Paruchuri S, Boscolo E, Mulliken JB, et al. Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood. 2006;108(3):915–21. https://doi.org/10.1182/blood-2006-03-006478.",
      "volume": "108",
      "year": "2006"
    },
    {
      "DOI": "10.1111/cpr.12633",
      "doi-asserted-by": "crossref",
      "key": "349_CR33",
      "unstructured": "Dong H, Diao H, Zhao Y, Xu H, Pei S, Gao J. Overexpression of matrix metalloproteinase-9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling. 2019;52(5):e12633."
    },
    {
      "DOI": "10.1016/j.lfs.2019.116946",
      "author": "MM Li",
      "doi-asserted-by": "publisher",
      "first-page": "116946",
      "journal-title": "Life Sci",
      "key": "349_CR34",
      "unstructured": "Li MM, Dong CX, Sun B, Lei HZ, Wang YL, Gong YB, et al. LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway. Life Sci. 2019;239:116946. https://doi.org/10.1016/j.lfs.2019.116946.",
      "volume": "239",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.survophthal.2019.02.005",
      "author": "KR Satterfield",
      "doi-asserted-by": "publisher",
      "first-page": "608",
      "issue": "5",
      "journal-title": "Surv Ophthalmol",
      "key": "349_CR35",
      "unstructured": "Satterfield KR, Chambers CB. Current treatment and management of infantile hemangiomas. Surv Ophthalmol. 2019;64(5):608–18. https://doi.org/10.1016/j.survophthal.2019.02.005.",
      "volume": "64",
      "year": "2019"
    },
    {
      "DOI": "10.1097/SCS.0000000000004745",
      "author": "MN Xu",
      "doi-asserted-by": "publisher",
      "first-page": "1876",
      "issue": "7",
      "journal-title": "The Journal of craniofacial surgery",
      "key": "349_CR36",
      "unstructured": "Xu MN, Zhang M, Xu Y, Wang M, Yuan SM. Individualized treatment for infantile hemangioma. The Journal of craniofacial surgery. 2018;29(7):1876–9. https://doi.org/10.1097/SCS.0000000000004745.",
      "volume": "29",
      "year": "2018"
    },
    {
      "DOI": "10.3892/mmr.2020.11409",
      "author": "L Yu",
      "doi-asserted-by": "publisher",
      "first-page": "3358",
      "issue": "4",
      "journal-title": "Mol Med Rep",
      "key": "349_CR37",
      "unstructured": "Yu L, Shu H, Xing L, Lv MX, Li L, Xie YC, et al. Silencing long non-coding RNA NEAT1 suppresses the tumorigenesis of infantile hemangioma by competitively binding miR-33a-5p to stimulate HIF1α/NF-κB pathway. Mol Med Rep. 2020;22(4):3358–66. https://doi.org/10.3892/mmr.2020.11409.",
      "volume": "22",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.lfs.2019.03.006",
      "author": "Y Wang",
      "doi-asserted-by": "publisher",
      "first-page": "22",
      "journal-title": "Life Sci",
      "key": "349_CR38",
      "unstructured": "Wang Y, Li M, Dong C, Ma Y, Xiao L, Zuo S, et al. Linc00152 knockdown inactivates the Akt/mTOR and Notch1 pathways to exert its anti-hemangioma effect. Life Sci. 2019;223:22–8. https://doi.org/10.1016/j.lfs.2019.03.006.",
      "volume": "223",
      "year": "2019"
    },
    {
      "DOI": "10.1111/cpr.12269",
      "author": "Z Li",
      "doi-asserted-by": "publisher",
      "first-page": "471",
      "issue": "4",
      "journal-title": "Cell Prolif",
      "key": "349_CR39",
      "unstructured": "Li Z, Shen J, Chan MT, Wu WK. TUG1: a pivotal oncogenic long non-coding RNA of human cancers. Cell Prolif. 2016;49(4):471–5. https://doi.org/10.1111/cpr.12269.",
      "volume": "49",
      "year": "2016"
    },
    {
      "DOI": "10.3389/fnmol.2019.00215",
      "author": "H Wang",
      "doi-asserted-by": "publisher",
      "first-page": "215",
      "journal-title": "Front Mol Neurosci",
      "key": "349_CR40",
      "unstructured": "Wang H, Liao S, Li H, Chen Y, Yu J. Long non-coding RNA TUG1 sponges Mir-145a-5p to regulate microglial polarization after oxygen-glucose deprivation. Front Mol Neurosci. 2019;12:215. https://doi.org/10.3389/fnmol.2019.00215.",
      "volume": "12",
      "year": "2019"
    },
    {
      "DOI": "10.1186/s12890-020-1084-3",
      "author": "N Qiu",
      "doi-asserted-by": "publisher",
      "first-page": "49",
      "issue": "1",
      "journal-title": "BMC pulmonary medicine",
      "key": "349_CR41",
      "unstructured": "Qiu N, Xu X, He Y. LncRNA TUG1 alleviates sepsis-induced acute lung injury by targeting miR-34b-5p/GAB1. BMC pulmonary medicine. 2020;20(1):49. https://doi.org/10.1186/s12890-020-1084-3.",
      "volume": "20",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.lfs.2020.117287",
      "author": "X Wu",
      "doi-asserted-by": "publisher",
      "first-page": "117287",
      "journal-title": "Life Sci",
      "key": "349_CR42",
      "unstructured": "Wu X, Zheng X, Cheng J, Zhang K, Ma C. LncRNA TUG1 regulates proliferation and apoptosis by regulating miR-148b/IGF2 axis in ox-LDL-stimulated VSMC and HUVEC. Life Sci. 2020;243:117287. https://doi.org/10.1016/j.lfs.2020.117287.",
      "volume": "243",
      "year": "2020"
    },
    {
      "DOI": "10.1146/annurev.pathol.4.110807.092222",
      "author": "YS Lee",
      "doi-asserted-by": "publisher",
      "first-page": "199",
      "issue": "1",
      "journal-title": "Annu Rev Pathol",
      "key": "349_CR43",
      "unstructured": "Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4(1):199–227. https://doi.org/10.1146/annurev.pathol.4.110807.092222.",
      "volume": "4",
      "year": "2009"
    },
    {
      "DOI": "10.3892/mmr.2018.9409",
      "author": "Z Fei",
      "doi-asserted-by": "publisher",
      "first-page": "4065",
      "issue": "4",
      "journal-title": "Mol Med Rep",
      "key": "349_CR44",
      "unstructured": "Fei Z, Qiu M, Qi X, Dai Y, Wang S, Quan Z, et al. MicroRNA-424 suppresses the proliferation of hemangioma-derived endothelial cells by targeting VEGFR-2. Mol Med Rep. 2018;18(4):4065–71. https://doi.org/10.3892/mmr.2018.9409.",
      "volume": "18",
      "year": "2018"
    },
    {
      "DOI": "10.3892/ijo.2017.3943",
      "author": "F Gao",
      "doi-asserted-by": "publisher",
      "first-page": "1821",
      "issue": "5",
      "journal-title": "Int J Oncol",
      "key": "349_CR45",
      "unstructured": "Gao F, Wang FG, Liu RR, Xue F, Zhang J, Xu GQ, et al. Epigenetic silencing of miR-130a ameliorates hemangioma by targeting tissue factor pathway inhibitor 2 through FAK/PI3K/Rac1/mdm2 signaling. Int J Oncol. 2017;50(5):1821–31. https://doi.org/10.3892/ijo.2017.3943.",
      "volume": "50",
      "year": "2017"
    },
    {
      "DOI": "10.3389/fendo.2020.00100",
      "author": "C Duan",
      "doi-asserted-by": "publisher",
      "first-page": "100",
      "journal-title": "Front Endocrinol",
      "key": "349_CR46",
      "unstructured": "Duan C, Allard JB. Insulin-like growth factor binding protein-5 in physiology and disease. Front Endocrinol. 2020;11:100. https://doi.org/10.3389/fendo.2020.00100.",
      "volume": "11",
      "year": "2020"
    },
    {
      "DOI": "10.1038/onc.2015.430",
      "author": "H Yang",
      "doi-asserted-by": "publisher",
      "first-page": "3647",
      "issue": "28",
      "journal-title": "Oncogene.",
      "key": "349_CR47",
      "unstructured": "Yang H, Liu P, Zhang J, Peng X, Lu Z, Yu S, et al. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b. Oncogene. 2016;35(28):3647–57. https://doi.org/10.1038/onc.2015.430.",
      "volume": "35",
      "year": "2016"
    }
  ],
  "reference-count": 47,
  "references-count": 47,
  "resource": {
    "primary": {
      "URL": "https://humgenomics.biomedcentral.com/articles/10.1186/s40246-021-00349-w"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genomics"
  ],
  "source": "Crossref",
  "title": [
    "LncRNA-TUG1 promotes the progression of infantile hemangioma by regulating miR-137/IGFBP5 axis"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "15"
}